• VX-765 for Caspase-1 Inflammation Research

  2026-09-30

  VX-765 enables selective interrogation of caspase-1-dependent IL-1β and IL-18 signaling, pyroptosis, and inflammatory disease biology. This workflow-focused guide covers cellular assays, biochemical validation, preclinical translation, and troubleshooting for experiments using its active metabolite VRT-043198.

• Shufeng Xingbi Therapy in Allergic Rhinitis Rats

  2026-09-29

  This preprint integrates behavioral, histological, immune, metabolic, and 16S rDNA measurements to examine how Shufeng Xingbi Therapy affects allergic rhinitis in rats. Its findings associate symptom improvement with reduced Th2-related inflammatory signals, altered intestinal microbial composition, and increased short-chain fatty acids, while the study design does not yet establish causality or clinical efficacy.

• Immunodominant P. vivax Epitopes for Surveillance

  2026-09-29

  A 2026 study combined computational antigen prioritization, peptide serology, multiplex validation, and conservation analysis to identify immunodominant B-cell epitopes for Plasmodium vivax surveillance. The strongest candidates showed species-discriminating serological performance, while MSP9_384–389 provided a potential signal for asymptomatic infection and hidden transmission reservoirs.

• Isoprinosine: From Viral Egress to Translation

  2026-09-28

  A translational framework for positioning Isoprinosine, or inosine pranobex, at the intersection of host-directed antiviral research, herpesvirus nuclear egress, and clinically relevant immunomodulation.

• TCAIM Controls OGDH Abundance and Mitochondrial Metabolism

  2026-09-28

  A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that binds OGDH and, with HSPA9 and LONP1, reduces its functional protein levels. The work reveals a proteostasis-based route for regulating a key TCA-cycle enzyme and connects OGDH abundance to mitochondrial carbohydrate metabolism.

• NBC19 and the Lactate–HMGB1 Sepsis Axis

  2026-09-27

  NBC19, a potent NLRP3 inflammasome inhibitor, offers a way to test whether inflammasome signaling contributes to inflammatory readouts alongside lactate-driven HMGB1 release. This article connects the two mechanisms while clarifying what current evidence does—and does not—show.

• EZ Cap™ Mouse IL-12 mRNA: Practical Delivery Workflows

  2026-09-26

  Pair capped, modified Mouse Interleukin-12 mRNA with a delivery system selected for the target cell or tissue—not just the transcript. A lung-targeted virus-mimicking particle study offers a useful extrahepatic delivery example, while the workflow below separates published findings from practical starting conditions to test in your own model.

• Recombinant Human FGF-19: Bench Workflow

  2026-09-25

  Recombinant Human FGF-19 provides a defined, tag-free ligand for FGFR4 binding and cell-based activity experiments, with product-level activity and purity specifications to guide assay setup. It is suitable for controlled in vitro research, but product specifications alone do not establish effects in a particular metabolic, tissue, or disease model.

• Nicotinamide Riboside Chloride: Assay Design

  2026-09-25

  Nicotinamide Riboside Chloride (NIAGEN) can support experiments on NAD+ biology, but interpreting a response requires more than measuring precursor exposure. This guide builds a reproducibility-focused framework for separating NAD+ target engagement from downstream metabolic effects—and clarifies what retinal stem-cell research can and cannot establish.

• Fenofibrate and Age-Independent Liver Enlargement

  2026-09-24

  Across chemically induced, naturally aged, and senescence-accelerated mouse models, the study found that Fenofibrate produced liver enlargement and PPARα–YAP pathway responses comparable to those in adult mice. The findings suggest that aging did not abolish this hepatic response, while also highlighting the need to distinguish liver growth and pathway activation from evidence of long-term safety or clinical benefit.

• WDR36 Links Glycolysis to Human TE Differentiation

  2026-09-24

  This study uses human stem cell-derived blastoids to show that WDR36 supports trophectoderm commitment and blastoid formation, with transcriptomic and metabolomic findings linking WDR36 interference to reduced glucose metabolism. The work further identifies an interaction between WDR36 and LDHA, connecting a developmental regulator with glycolytic control while leaving important questions about embryo-level validation and mechanism for future study.

• Ferroptosis Research Beyond Single-Pathway Inhibition

  2026-09-23

  A study of H-151 reveals that ferroptosis can be suppressed through radical trapping as well as STING inhibition. For translational researchers, the finding sharpens a practical question: how can experiments distinguish pathway effects from direct control of lipid peroxidation? ML-210 provides a complementary way to probe ferroptotic cell death.

• From Carbon-Ion Ferroptosis to IL-2 Test Strategy

  2026-09-23

  A translational framework connecting carbon-ion radiotherapy, DHODH suppression, ferroptosis, macrophage polarization, and a carefully staged IL-2, human recombinant research workflow.

• IL-7, Human Recombinant in Immune Assays

  2026-09-22

  IL-7, human recombinant supports controlled studies of lymphoid-cell survival and signaling. This article connects IL-7 assay design with new mechanistic insights into SARS-CoV-2 PLpro regulation of ER proteins, while clearly separating established evidence from experimental opportunity.

• From Membrane Disruption to Immune-Enabled MRSA Research

  2026-09-22

  YZ462 illustrates how membrane biology, biofilm testing, and mechanistic validation can reshape antibacterial discovery against MRSA. This article extends that evidence into a translational research framework, positioning Recombinant Human IL-12 as a controlled host-response variable rather than an unvalidated therapeutic claim.

8514 records 1/568 page Next 12345 下5页 Last page